Form D · Biotechnology

MitoChem Therapeutics, Inc.

Charleston, SC · CIK 0001836268

Offering snapshot reported Dec 18, 2020 · SEC filing

Reported sold
$236K
Offering amount: $300K
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 2, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$118K$236KDec 17, 2020: $235,766.00Dec 17, 2020Dec 18, 2020: $235,766.00Dec 18, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 18, 2020Amendment$235,766$0vs Dec 17, 20207SEC filing
Dec 17, 2020Initial$235,766No comparison7SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-383566

Source: Form D, filed Dec 18, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gyda Caren Beeson Director
Baerbel Rohrer Director
Rick G. Schnellman Director
Michael Voevodsky Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
645 Meeting Street
Charleston, SC, 29403